PDCD1 and head and neck squamous cell carcinoma: Our study is the first to show that PDCD1 methylation predicts the outcome in HNSCC patients, accordingly, potentially aiding the identification of HNSCC patients who might benefit from adjuvant treatment after radical surgical resection, particularly in the context of immunomodulatory therapies.